Baxter Spectrum IQ Infusion Pump Recall: Defective Power Adapter May Fail Over Time
Baxter recalls Spectrum IQ infusion pumps with serial numbers listed in the record due to a potentially defective AC power adapter that may fail over time.
Lower-risk recall
Potentially defective component in the AC power adapter which may fail over time.
Contact the company
What happened, in plain English
Baxter is recalling Spectrum IQ infusion pumps with specific serial numbers because a component in the AC power adapter could fail over time. This could lead to the pump not working properly during fluid administration. Read more at govinfonow.com/recall/63032-baxter-spectrum-iq-infusion-pump-recall-defective-power-adapter-may.
Source Summary by GovInfoNow · govinfonow.com/recall/63032-baxter-spectrum-iq-infusion-pump-recall-defective-power-adapter-may · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1487-2021
Cite this page
“Baxter Spectrum IQ Infusion Pump Recall: Defective Power Adapter May Fail Over Time.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63032-baxter-spectrum-iq-infusion-pump-recall-defective-power-adapter-may. Based on FDA recall #Z-1487-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1487-2021%22&limit=1).
Why it’s dangerous
The AC power adapter in the pump may fail over time, potentially causing the pump to stop working properly. This could lead to improper fluid administration if the pump is not functioning correctly.
Who’s affected
Patients using Baxter Spectrum IQ infusion pumps with the listed serial numbers are affected. Healthcare providers and caregivers who use these pumps are at risk if they have the recalled units.
How to tell if you have this one
Check the serial number on your Spectrum IQ infusion pump. The affected units have specific serial numbers listed in the recall notice.
- Brand
Baxter- Category
Medical device
What to do — step by step
Check Serial Number
Look for the serial number on your pump's label to confirm if it's in the list of affected units.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 24 states.
FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of AL, AR, CA, CT, FL, IA, IN, LA, MA, MD, ME, MN, MO, MS, MT, NC, NJ, NY, OH, PA, RI, SC, TN, TX and the country of Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arkansas, California, Connecticut, Florida, Indiana, Iowa, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Texas.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Baxter recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1487-2021 (March 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1487-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.